IL100858A - 2-Amino-1,2,3,4-Tetrahydronaphthalene and 3-Aminochromes are converted into a pharmaceutical composition ring containing them and a process for their preparation - Google Patents
2-Amino-1,2,3,4-Tetrahydronaphthalene and 3-Aminochromes are converted into a pharmaceutical composition ring containing them and a process for their preparationInfo
- Publication number
- IL100858A IL100858A IL10085892A IL10085892A IL100858A IL 100858 A IL100858 A IL 100858A IL 10085892 A IL10085892 A IL 10085892A IL 10085892 A IL10085892 A IL 10085892A IL 100858 A IL100858 A IL 100858A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- alkyl
- mixture
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Lubricants (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11476092A IL114760A (en) | 1991-02-08 | 1992-02-03 | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65358391A | 1991-02-08 | 1991-02-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL100858A0 IL100858A0 (en) | 1992-11-15 |
IL100858A true IL100858A (en) | 1996-03-31 |
Family
ID=24621480
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10085892A IL100858A (en) | 1991-02-08 | 1992-02-03 | 2-Amino-1,2,3,4-Tetrahydronaphthalene and 3-Aminochromes are converted into a pharmaceutical composition ring containing them and a process for their preparation |
IL11476092A IL114760A (en) | 1991-02-08 | 1992-02-03 | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
IL11476095A IL114760A0 (en) | 1991-02-08 | 1995-07-27 | Division from 100858 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes and intermediates thereto |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11476092A IL114760A (en) | 1991-02-08 | 1992-02-03 | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
IL11476095A IL114760A0 (en) | 1991-02-08 | 1995-07-27 | Division from 100858 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes and intermediates thereto |
Country Status (26)
Country | Link |
---|---|
US (2) | US5426226A (zh) |
EP (2) | EP0498590B1 (zh) |
JP (1) | JP3283892B2 (zh) |
KR (1) | KR100219995B1 (zh) |
CN (2) | CN1036392C (zh) |
AT (2) | ATE197145T1 (zh) |
AU (2) | AU653197B2 (zh) |
BR (1) | BR9200426A (zh) |
CA (1) | CA2060815C (zh) |
CZ (1) | CZ288067B6 (zh) |
DE (2) | DE69231538T2 (zh) |
DK (2) | DK0712837T3 (zh) |
ES (2) | ES2153071T3 (zh) |
FI (1) | FI920526A (zh) |
GR (2) | GR3023601T3 (zh) |
HU (3) | HU225163B1 (zh) |
IE (1) | IE920417A1 (zh) |
IL (3) | IL100858A (zh) |
MX (1) | MX9200505A (zh) |
MY (1) | MY116454A (zh) |
NO (1) | NO301825B1 (zh) |
NZ (2) | NZ241495A (zh) |
PT (1) | PT712837E (zh) |
RU (2) | RU2057751C1 (zh) |
YU (1) | YU48927B (zh) |
ZA (1) | ZA92767B (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE149480T1 (de) * | 1990-08-15 | 1997-03-15 | Lilly Co Eli | Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane |
DK0712837T3 (da) * | 1991-02-08 | 2000-11-20 | Lilly Co Eli | Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphtalener og 3-aminochromaner |
US5434174A (en) * | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
WO1994022495A1 (en) * | 1993-03-31 | 1994-10-13 | The Trustees Of The University Of Pennsylvania | Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents |
IL110857A0 (en) * | 1993-09-09 | 1994-11-28 | Lilly Co Eli | Cessation of tobacco use |
SE9601110D0 (sv) * | 1996-03-22 | 1996-03-22 | Astra Ab | Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
US6355674B1 (en) | 1997-04-30 | 2002-03-12 | Eli Lilly And Company | Aminotetralins as 5-HT1D α Agonists |
AU7163598A (en) * | 1997-04-30 | 1998-11-24 | Eli Lilly And Company | Aminotetralins as 5-ht1dalpha agonists |
CN1256085C (zh) | 1997-07-01 | 2006-05-17 | 美国辉瑞有限公司 | 舍曲林盐和舍曲林的缓释剂型 |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
KR20010079778A (ko) * | 1998-09-09 | 2001-08-22 | 이시하라 겐조 | 제초제로 유용한 융합-벤젠 유도체 |
FR2792529B1 (fr) * | 1999-04-26 | 2001-09-28 | Sod Conseils Rech Applic | Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines |
US6792563B1 (en) * | 2000-04-28 | 2004-09-14 | Intel Corporation | Method and apparatus for bus activity tracking |
WO2003068227A1 (en) * | 2002-02-13 | 2003-08-21 | Pharmagene Laboratories Limited | 5-ht2b receptor antagonists |
SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
SE0301794D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use III |
SE0301798D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use IV |
SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ192641A (en) * | 1979-01-26 | 1984-10-19 | Hoffmann La Roche | Substituted acetophenones and pharmaceutical compositions |
SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
US5214156A (en) * | 1988-03-25 | 1993-05-25 | The Upjohn Company | Therapeutically useful tetralin derivatives |
CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
CA1335106C (en) * | 1989-02-27 | 1995-04-04 | John Mehnert Schaus | Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
FR2647365B1 (fr) * | 1989-05-24 | 1991-08-30 | Inst Francais Du Petrole | Catalyseur multifonctionnel pour le traitement des gaz d'echappement des moteurs a combustion interne, contenant de l'uranium, au moins un promoteur de l'uranium et au moins un metal precieux et sa preparation |
SE8901889D0 (sv) * | 1989-05-26 | 1989-05-26 | Astra Ab | Novel 8-substituted-2-aminotetralines |
ATE172712T1 (de) * | 1989-05-31 | 1998-11-15 | Upjohn Co | Zns-wirksame 8-heterocyclyl-2-aminotetralin derivate |
DE3919624A1 (de) * | 1989-06-15 | 1990-12-20 | Boehringer Ingelheim Kg | Neue 2,5-diaminotetraline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
AU631017B2 (en) * | 1989-10-23 | 1992-11-12 | Sumitomo Chemical Company, Limited | 5-substituted-2,4-diphenylpyrimidine derivatives, their production and use |
SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
ATE149480T1 (de) * | 1990-08-15 | 1997-03-15 | Lilly Co Eli | Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane |
DK0712837T3 (da) * | 1991-02-08 | 2000-11-20 | Lilly Co Eli | Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphtalener og 3-aminochromaner |
-
1992
- 1992-02-03 DK DK96200393T patent/DK0712837T3/da active
- 1992-02-03 IL IL10085892A patent/IL100858A/en not_active IP Right Cessation
- 1992-02-03 AT AT96200393T patent/ATE197145T1/de not_active IP Right Cessation
- 1992-02-03 ZA ZA92767A patent/ZA92767B/xx unknown
- 1992-02-03 NZ NZ241495A patent/NZ241495A/en not_active IP Right Cessation
- 1992-02-03 DE DE69231538T patent/DE69231538T2/de not_active Expired - Fee Related
- 1992-02-03 AT AT92300887T patent/ATE151419T1/de not_active IP Right Cessation
- 1992-02-03 ES ES96200393T patent/ES2153071T3/es not_active Expired - Lifetime
- 1992-02-03 ES ES92300887T patent/ES2102456T3/es not_active Expired - Lifetime
- 1992-02-03 PT PT96200393T patent/PT712837E/pt unknown
- 1992-02-03 EP EP92300887A patent/EP0498590B1/en not_active Expired - Lifetime
- 1992-02-03 IL IL11476092A patent/IL114760A/xx not_active IP Right Cessation
- 1992-02-03 DK DK92300887.4T patent/DK0498590T3/da active
- 1992-02-03 DE DE69218813T patent/DE69218813T2/de not_active Expired - Fee Related
- 1992-02-03 EP EP96200393A patent/EP0712837B1/en not_active Expired - Lifetime
- 1992-02-05 CZ CS1992332A patent/CZ288067B6/cs not_active IP Right Cessation
- 1992-02-06 MY MYPI92000186A patent/MY116454A/en unknown
- 1992-02-06 KR KR1019920001720A patent/KR100219995B1/ko not_active IP Right Cessation
- 1992-02-06 MX MX9200505A patent/MX9200505A/es not_active IP Right Cessation
- 1992-02-06 JP JP02109892A patent/JP3283892B2/ja not_active Expired - Fee Related
- 1992-02-06 NO NO920489A patent/NO301825B1/no unknown
- 1992-02-06 AU AU10775/92A patent/AU653197B2/en not_active Ceased
- 1992-02-07 RU SU925011019A patent/RU2057751C1/ru not_active IP Right Cessation
- 1992-02-07 CN CN92100794A patent/CN1036392C/zh not_active Expired - Fee Related
- 1992-02-07 FI FI920526A patent/FI920526A/fi not_active IP Right Cessation
- 1992-02-07 YU YU12992A patent/YU48927B/sh unknown
- 1992-02-07 IE IE041792A patent/IE920417A1/en not_active IP Right Cessation
- 1992-02-07 CA CA002060815A patent/CA2060815C/en not_active Expired - Fee Related
- 1992-02-07 BR BR929200426A patent/BR9200426A/pt not_active Application Discontinuation
- 1992-02-07 HU HU9500495A patent/HU225163B1/hu not_active IP Right Cessation
- 1992-02-07 HU HU9200396A patent/HU221184B1/hu not_active IP Right Cessation
-
1993
- 1993-10-21 US US08/140,903 patent/US5426226A/en not_active Expired - Fee Related
-
1994
- 1994-08-24 NZ NZ264302A patent/NZ264302A/en not_active IP Right Cessation
- 1994-12-20 RU RU94044322A patent/RU2105756C1/ru not_active IP Right Cessation
- 1994-12-22 AU AU81687/94A patent/AU664520B2/en not_active Ceased
-
1995
- 1995-06-22 HU HU95P/P00389P patent/HU211848A9/hu unknown
- 1995-07-27 IL IL11476095A patent/IL114760A0/xx unknown
- 1995-08-22 US US08/517,781 patent/US5571942A/en not_active Expired - Fee Related
-
1996
- 1996-02-06 CN CN96103586A patent/CN1052218C/zh not_active Expired - Fee Related
-
1997
- 1997-05-30 GR GR970401244T patent/GR3023601T3/el unknown
-
2001
- 2001-01-04 GR GR20010400008T patent/GR3035190T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL100858A (en) | 2-Amino-1,2,3,4-Tetrahydronaphthalene and 3-Aminochromes are converted into a pharmaceutical composition ring containing them and a process for their preparation | |
AU728329B2 (en) | New substituted biphenyl or phenylpyridine compounds, a process for their preparation and pharmaceutical compositions containing them | |
EA004306B1 (ru) | Нестероидные (гетеро)циклически замещенные ациланилиды, обладающие смешанным гестагенным и андрогенным действием | |
JP2001521529A (ja) | 置換へテロ芳香環5−ht▲下1f▼アゴニスト | |
HU217590B (hu) | Eljárás 6-os helyen heterociklusos csoporttal helyettesített 4-amino-1,3,4,5-tetrahidro-benz[c,d]indolok és a vegyületeket tartalmazó gyógyszerkészítmények előállítására | |
CZ281137B6 (cs) | V jádru substituovaný 2-amino-1,2,3,4-tetrahydronaftalen-3-aminochroman a 3-aminothiochroman, způsob jejich přípravy a farmaceutické prostředky je obsahující | |
CZ137193A3 (en) | Isoxazole derivative for treating intestine irritation syndrome and pharmaceutical preparation in which it is comprised | |
RU2093507C1 (ru) | 8-замещенные-2-аминотетралиновые производные и способы из получения | |
JPH02268151A (ja) | 環置換された2―アミノ―1,2,3,4―テトラヒドロナフタレンおよび3―アミノクロマン類 | |
RU2062775C1 (ru) | 6-гетероциклическизамещенные 4-амино-1,2,2а,3,4,5-гексагидробенз-(cd)-индолы или их фармацевтически приемлемые соли и способы их получения | |
JPH06211655A (ja) | 乗物酔いおよび嘔吐症の処置用6−ヘテロ環−4−アミノ−1,3,4,5−テトラヒドロベンズ[cd]インドール類 | |
US6166020A (en) | Aryl and heteroaryl alkoxynaphthalene derivatives | |
US5750524A (en) | Remedy for hyperlipidemia | |
JP2004531526A (ja) | 5員複素間誘導体、その製造法及びその医薬としての使用 | |
AU2004312284B2 (en) | Non-nucleotide reverse transcriptase inhibitors | |
IE19970857A1 (en) | Ring-substituted 2-amino-1, 2, 3, 4-tetra-hydronaphthalenes and 3-aminochromanes | |
JPH06211654A (ja) | 乗物酔いおよび嘔吐処置用6−ヘテロ環−4−アミノ−1,2,2a,3,4,5−ヘキサヒドロベンズ[cd]インドール類 | |
IE83295B1 (en) | Ring-substituted 2-amino-1, 2, 3, 4-tetra-hydronaphthalenes and 3-aminochromanes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |